Experience

Karuna Therapeutics – $862.5 Million Follow-on Offering

September 7, 2022

Cooley advised the underwriters in Karuna Therapeutics’ $862.5 million follow-on offering of 4,011,628 shares of common stock at a public offering price of $215 per share. Karuna is a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psychiatric and neurological conditions. Partners Richard Segal, Jean Park, Div Gupta and associate Darah Protas led the Cooley team.

Related contacts

Richard Segal
Partner, New York
Jean Park
Partner, New York
Div Gupta
Partner, New York
Darah Protas
Associate, Washington DC
Charles York
Associate, New York
Katie Lapidus
Associate, Washington DC
Quay Strozier
Associate, Washington DC
Katherine King
Associate, Washington DC

argenx – $805 Million Follow-On Offering

March 24, 2022

Cooley advised the underwriters in argenx’s $805 million follow-on offering of 2,683,334 ordinary shares, including ordinary shares represented by American Depositary Shares, at a public offering price of $300.00 per share. JP Morgan, Morgan Stanley, Cowen and SVB Leerink acted as joint bookrunners for the offering. argenx is a commericial-stage biotechnology company developing a pipeline of differentiated antibody-based therapies for the treatment of severe autoimmune diseases and cancer. Partners Rich Segal and Div Gupta led the Cooley team.

Related contacts

Richard Segal
Partner, New York
Div Gupta
Partner, New York
Evan Leitner
Associate, New York
Charles York
Associate, New York
Ryan Walker
Associate, New York

Warby Parker – Direct Listing

October 13, 2021

Cooley advised the financial advisers on Warby Parker’s direct listing of 77,741,942 shares of Class A common stock. The direct-to-consumer eyewear brand’s securities now trade on the New York Stock Exchange under the symbol “WRBY.” Partners Nicole Brookshire, Richard Segal and David Peinsipp led the Cooley team advising Warby Parker’s financial advisers.

Read more

Related contacts

Richard Segal
Partner, New York
David Peinsipp
Partner, San Francisco
Evan Leitner
Associate, New York
Charles York
Associate, New York
Rebecca Ross
Special Counsel, Washington DC
Phil Mitchell
Partner, New York
Jennifer Shanley
Special Counsel, New York
Natasha Leskovsek
Of Counsel, Washington DC
Bobby Ghajar
Partner, Los Angeles Santa Monica
Randy Sabett
Special Counsel, Washington DC
Allison Kutner
Associate, New York
Stephanie Gentile
Partner, New York
Francis Wheeler
Partner, Colorado

CS Disco – $246 Million IPO

July 21, 2021

Cooley advised CS Disco on its $246.4 million initial public offering of 7,700,000 shares of common stock, which includes the full exercise of the underwriters’ option to purchase additional shares. CS Disco, whose securities now trade on the New York Stock Exchange under the symbol LAW, is the leading provider of software-as-a-service solutions developed by lawyers for lawyers. Partners Nicole Brookshire, Jodie Bourdet and Nicolas Dumont led the Cooley team.

Related contacts

Jodie Bourdet
Partner, San Francisco
Nicolas H.R. Dumont
Partner, New York
Trey Reilly
Associate, New York
Charles York
Associate, New York
Dennis F. Craig II
Associate, Washington DC

Sprinklr – $293 Million IPO

June 26, 2021

Cooley advised Sprinklr on its $292.6 million initial public offering of 18,287,500 shares of Class A common stock, which includes the full exercise of the underwriters’ option to purchase additional shares. Sprinklr, whose securities now trade on the New York Stock Exchange under the symbol CXM, is the unified customer experience management platform for modern enterprises. Partners Nicole Brookshire, Josh Kaufman and Jaime Chase led the Cooley team.

Related contacts

Josh Kaufman
Partner, New York
Jaime L. Chase
Partner, Washington DC
Charles York
Associate, New York
View more